[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:inflammatory-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":41,"states":42},"Inflammatory Disorder",5,4,[8,16,22,28,34],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04638647","Secukinumab Open Label Roll-over Extension Protocol",[12],"Phase 4","RECRUITING","2026-08-26T02:17:15.156099Z","2026-04-29T02:57:57.089983Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05656378","A Repository to Study Host-Microbiome Interactions in Health and Disease",[],"2026-08-26T02:17:49.709549Z","2026-05-13T02:55:06.369036Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT01280825","The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing",[],"2026-08-26T02:16:01.910993Z","2026-05-13T02:55:06.070857Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT01143454","Characterization of Patients With Uncommon Presentations and\u002For Uncommon Diseases Associated With the Cardiovascular System",[],"2026-08-26T02:17:51.502023Z","2026-05-13T02:55:06.068011Z",{"nct_id":35,"title":36,"phases":37,"status":38,"updated_at":39,"content_modified":40},"NCT00001351","Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders",[],"ENROLLING_BY_INVITATION","2026-08-26T02:18:47.742071Z","2026-06-16T05:54:07.943564Z",[],[43],{"state":44,"count":6,"slug":45},"Maryland","maryland"]